Literature DB >> 20871724

Pharmacogenomics in the clinic: new questions about tamoxifen.

Michael Castro1.   

Abstract

Entities:  

Year:  2006        PMID: 20871724      PMCID: PMC2794617          DOI: 10.1200/JOP.2006.2.2.100

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  3 in total

1.  Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker?

Authors:  Frankie Ann Holmes; Jeffrey D Liticker
Journal:  J Oncol Pract       Date:  2005-11       Impact factor: 3.840

2.  Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.

Authors:  Susan Nowell; Carol Sweeney; Maria Winters; Angie Stone; Nicholas P Lang; Laura F Hutchins; Fred F Kadlubar; Christine B Ambrosone
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

3.  CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Authors:  Yan Jin; Zeruesenay Desta; Vered Stearns; Bryan Ward; Herbert Ho; Kyung-Hoon Lee; Todd Skaar; Anna Maria Storniolo; Lang Li; Adjei Araba; Rebecca Blanchard; Anne Nguyen; Lynda Ullmer; Jill Hayden; Suzanne Lemler; Richard M Weinshilboum; James M Rae; Daniel F Hayes; David A Flockhart
Journal:  J Natl Cancer Inst       Date:  2005-01-05       Impact factor: 13.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.